Davorka Messmer, Ph.D., joined Nurix in 2022 and has served as Vice President of Discovery Biology since June 2024. Dr. Messmer has more than 10 years of drug development experience in small molecules and peptide therapeutics and over 20 years of experience in immunology and oncology. Prior to joining Nurix, Dr. Messmer held roles at Johnson & Johnson, Plexium and Inception Sciences. She earned her B.S. in Biochemistry from the University of Duesseldorf and her Ph.D. in Immunology from the Rockefeller University in NY.
'